Abstract
To explore the application of computed tomography (CT)-enhanced radiomics for the risk-grade prediction of gastrointestinal stromal tumors (GIST). GIST patients (n = 292) confirmed by surgery or endoscopic pathology during June 2013–2019 were reviewed and categorized into low-grade (very low to low risk) and high-grade (medium to high risk) groups. The tumor region of interest (ROI) was depicted layer by layer on each patient’s enhanced CT venous phase images using the ITK-SNAP. The texture features were extracted using the Analysis Kit (AK) and then randomly divided into the training (n = 205) and test (n = 87) groups in a ratio of 7:3. After dimension reduction by the least absolute shrinkage and the selection operator algorithm (LASSO), a prediction model was constructed using the logistic regression method. The clinical data of the two groups were statistically analyzed, and the multivariate regression prediction model was constructed by using statistically significant features. The ROC curve was applied to evaluate the prediction performance of the proposed model. A radiomics-prediction model was constructed based on 10 characteristic parameters selected from 396 quantitative feature parameters extracted from the CT images. The proposed radiomics model exhibited effective risk-grade prediction of GIST. For the training group, the area under curve (AUC), sensitivity, specificity, and accuracy rate were 0.793 (95%CI: 0.733–0.854), 83.3%, 64.3%, and 72.7%, respectively; the corresponding values for the test group were 0.791 (95%CI: 0.696–0.886), 84.2%, 69.3%, and 75.9%, respectively. There were significant differences in age (t value: − 3.133, P = 0.008), maximum tumor diameter (Z value: − 12.163, P = 0.000) and tumor morphology (χ2 value:10.409, P = 0.001) between the two groups, which were used to establish a clinical prediction model. The area under the receiver operating characteristic curve of the clinical model was 0.718 (95%CI: 0.659–0.776). The proposed CT-enhanced radiomics model exhibited better accuracy and effective performance than the clinical model, which can be used for the assessment of risk grades of GIST.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
Being the most common mesenchymal tumors of the digestive tract, gastrointestinal stromal tumors (GIST) are potential malignancies that readily metastasize to the liver and abdominal cavity with a high postoperative recurrence rate1,2,3. With reference to the 2008 National Institutes of Health (NIH) classification system, GISTs with different biological behaviors can be categorized into 4 grades: high-risk, intermediate-risk, low-risk, and very low-risk4. Treatment of patients with low/very low-risk GIST mainly involves surgical resection. For the early-stage and small tumors, the treatment options include minimally invasive surgery with smaller surgical wounds, rapider postoperative recovery, and fewer complications, whereas varying degrees of imatinib adjuvant treatments have been deemed necessary for high-risk tumors after surgery5. Therefore, the accurate diagnosis and risk stratification of GISTs before surgery is considered crucial for the determination of appropriate treatment options and patient prognosis.
With the increase in the availability of image recognition tools and the advancement in computer technology, the uses of medical images are no longer limited for visual judgment. The digital information contained therein can be mined and quantified to facilitate clinical decision-making6. As a novel method, radiomics has been employed to obtain these implicit data and transform them into information that can facilitate the prediction and evaluation of diseases to guide treatments approaches7,8,9,10. The present study aims to discuss the application of CT-enhanced radiology model for the risk-grade prediction of GIST.
Data and method
Clinical data
This study was approved by the ethics committee of the Huzhou Central Hospital (Affiliated Central Hospital Huzhou University), and all patients signed informed consent. A total of 384 GIST cases registered during June 2013–2019 were reviewed. A total of 37 cases with no enhanced CT examination, 45 cases with a previous treatment history, and 10 cases with poor image quality were excluded, and, finally, 292 cases were included in this study based on the following inclusion criteria:
-
1.
Pathologically confirmed GIST patients who underwent enhanced CT examination;
-
2.
Patients who did not receive any type of treatment (such as surgery, biopsy, radiotherapy, chemotherapy, or hormone therapy) before their enhanced CT examination;
-
3.
Patients with high-quality CT imaging data with no artifact, where the lesion was clearly evident; and
-
4.
Patients whose detailed pathological report with explicit risk classification was available.
Methods
Routine plain scan and multi-phase enhanced scan were performed with the Aquilion 16 Slice Spiral CT (Toshiba, Japan) using the following scanning parameters: tube voltage: 120 kV, tube current: 150 MAS, scanning layer thickness: 0.5 mm, reconstruction layer thickness: 5 mm, layer spacing: 2 mm; 18-G venous indwelling needle embedded in the elbow vein, and non-ionic contrast agent iodofol injected at 2.5 mL/s with the injection volume of 1.5 mL/kg.
Radiomics analysis
The Artificial Intelligence Kit (AI-Kit, Version: 3.0.1.A) was used for the analysis. Following the radiomics methods, the software delivered a series of imaging features by analyzing the heterogenicity of the target region.
Lesion segmentation
The venous phase images of all patients were imported into the image processing software ITK-SNAP (version 3.6.0, http://www.itksnap.org/)7 in the DICOM format. Two doctors unaware of the pathology manually delineated, segmented, and fused all layers of the lesions for a layer by layer display, followed by merging them into the 3D volume of interest (VOI) (Fig. 1a,b). In case of a disagreement, the two doctors had a discussion with each other until reaching a consensus. Given the density of GIST and the characteristics of the enhancement technique, the venous phase was selected for tumor delineation in order to identify the tumor boundary and avoid error.
Extraction of radiomics features
The ROI file and the original of image of the segmented tumor were synchronously imported into the AK software in order to calculate the parameters of quantitative radiology features, including VOI. A total of 396 features of 5 categories, including the histogram feature, morphology feature, gray level co-occurrence matrix feature, run length matrix feature, and gray area size matrix feature were extracted for each patient.
Feature pre-processing
The extracted features were pre-processed before feature screening, as follows: (1) the median number of the feature was used when the omissive or abnormal values developed. (2) The dataset was randomly divided into the training group (n = 205) and the test group (n = 87) in the ratio of 7:3. The data of the training group were used for model construction, while those of the test group were used to validate the model accuracy and test its generalization power. (3) The features were standardized with the Z-score (minus the mean value divided by the standard deviation) in order to eliminate the interference between the feature dimensions.
Feature screening and modeling
For the training group, Spearman correlation analysis was first conducted in order to calculate the redundancy among feature parameters, and the threshold value of 0.9 was set to eliminate the strongly correlated feature parameters and only one of them was retained. Next, tenfold cross validation was performed via LASSO regression, and the features with non-zero coefficients were selected. To detect the multi-collinearity between variables in the combined model, the variance inflation factor (VIF) was used to perform the collinearity diagnosis with the VIFs > 5 indicating a severity collinearity.The parameters of the selected features were used to establish the model for GISK risk grading through logic regression analysis.
Statistical analysis
The R (Version: 3.4.4) and SPSS (SPSS23.0) software were used for statistical analyses. The Kolmogorov–Smirnov test was performed to determine whether the data obeyed normal distribution. The t-test (normal distribution) and the Mann–Whitney U (skewed distribution) test were employed for comparison between the two groups of data. The data were represented as mean ± standard deviation (x ± s). The χ2 test was used to compare the data between the two groups of patients. The parameters such as accuracy, sensitivity, specificity, and area under curve (AUC) were used to evaluate the predication power of the model.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional (Huzhou Central Hospital, Affiliated Central Hospital Huzhou University) and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Results
General demographics
A total of 292 patients (men: 140, women: 152, age: 29–90 years; average age: 61 ± 12 years) were categorized into the low-risk group (n = 127; very-low-risk cases: 32, low-risk cases: 95) and the high-risk group (n = 165; intermediate-risk cases: 46, high-risk cases; 119). A comparison between the general information of the two groups is listed under Table 1. No significant difference was noted with respect to the patient gender between the two groups. However, difference in the onset age exhibited a certain degree of significance. For instance, the onset age in the high-risk group was greater than that in the low-risk group. No significant difference in the degree of tumor enhancement was noted between the two groups, although the parameters of maximum tumor diameter and tumor morphology showed certain statistical significance.
A clinical model for GIST risk grading was constructed with age, maximum tumor diameter and tumor morphology, which showed an AUC of 0.718 (95%CI: 0.659–0.776), with the sensitivity, and specificity of 66.1% and 61.9%.
Radiomics model
A total of 396 quantitative imaging feature parameters were extracted using the AK software, and the inter-feature redundancy was first eliminated with the Spearman method to yield 20 features. These features were screened with the LASSO regression, and 10 features with higher predicative values were retained (Fig. 2a,b), which included 2 morphology features, 6 Gy-level co-occurrence matrix features, and 2 run-length matrix features. The feature parameters and their corresponding coefficients are listed under Table 2. All VIF values were less than 5. The radiomics score for each patient was calculated with the following formula:
Rad score = 0.676 − 0.091 × feature 1 + 2.535 × feature 2 − 0.298 × feature 3 + 0.368 × feature 4 + 0.234 × feature 5 − 0.076 × feature 6 + 0.104 × feature 7 + 0.076 × feature 8 + 0.051 × feature 9 + 0.031 × feature 10.
Statistical significance was recorded for the rad score in differentiating between the high- and low-risk GIST for both the training and test groups, and the rad score was found to be higher in the high-risk group than in the low-risk group (Fig. 3a,b).
A predicative model for GIST risk grading was constructed from these feature parameters via the logic regression analysis. For the training group, the model showed an AUC of 0.793 (95%CI: 0.733–0.854), with the sensitivity, specificity, and accuracy of 83.3%, 64.3%, and 72.7%, respectively. For the validation group, the model’s AUC was 0.791 (95%CI: 0.696–0.886), with the sensitivity, specificity, and accuracy of 84.2%, 69.3%, and 75.9%, respectively. The cumulative results indicated that the proposed model possesses better predicative power than the clinical model (Table 3; Fig. 4a–c).
Discussion
The study features
With the recent development of artificial intelligence, radiomics methods have witnessed extensive application in disease diagnosis. Radiomics can extract feature data from images in a high-throughput manner that can be quantitatively analyzed for the transformation of the conventional medical images into quantitative data8,9,10,11,12. The results of this study yielded from the analysis of these data combined with the clinical and pathological information can be together used to guide clinical practices. As GIST risk grading is crucial for deciding the best clinical therapeutic option, and enhancement CT is advantageous owing to its convenience of use, intuitiveness, and non-invasiveness, the proposed approach serves as an important method of pre-surgical auxiliary examination13–17.
In the present study, ROI delineation is a premise for feature extraction. Segmentation of tumor ROI influences the feature extraction directly, where some features are extremely sensitive to the segmentation boundary. Past studies have demonstrated that the local tumor components cannot fully represent the tumor in general and that analyses based on the global domains of tumors can indicate tumor heterogeneity in a more accurate and reliable manner8,12,16. Therefore, in the current study, all layers containing the tumor parenchyma in the venous phase images of the enhanced CT were delineated layer by layer and then fused into a three-dimensional (3D) structure in order to ensure the generality and accuracy of the extracted feature parameters.
In addition to the conventional first-order histogram and morphology features, we employed the AK software to mine high-order texture parameters that are richer inside the tumors. The internal texture of GIST with different risk grading is mixed and locally irregular, but globally regular grey characteristics in the conventional CT images cannot be visually distinguished. These high-order texture parameters quantify the feature of gray level change within the tumor area and between the adjacent organs for the quantitative analysis of the tumor17, which provides additional valuable information for the auxiliary diagnosis or prognosis prediction.
Analysis of feature parameters
In this study, after feature screening, LASSO retained two morphology features: surface-volume ratio and volume. The morphological features mainly described the 3D size and the shape of tumors18,19, among which the surface-volume ratio equaled to the surface of the VOI divided by the volume, while the tumor volume was calculated by multiplying the pixel numbers of the tumor area by the pixel size, which provided information about the lesion size. Similar to previous research20, our analysis showed that there was significant difference in age, maximum tumor diameter and tumor morphology between the two groups. The onset age in the high-risk group was greater than that in the low-risk group, so we speculated that higher grade tumors may present later in life. Among the final 10 features selected for model construction, the coefficient of volume was the largest, which indicated that the lesion size and the morphology of GIST were closely related to risk grading. The larger the volume, the smaller the SurfaceVolumeRatio, the higher the risk of GIST. These observation were further backed by the fact that only the parameters of maximum tumor diameter and tumor morphology exhibited statistical significance in the analysis of the general patient information.
The gray level co-occurrence matrix(GLCM) represents the joint probability of some pixel sets with a certain gray value11. The GLCM Correlation reflects the local gray level correlation in the image. Nine GLCM parameters (such as inertia, total entropy, full angle energy, correlation, and full-angle diagonal correlation) are included in the feature-screening results. These features describe the 2D spatial distribution of gray intensity10,19 that suggest, from another perspective, that the differences in the inner texture of tumors are important factors that influence tumor risk grading. The more uniform the GLCM matrix element value, the greater the correlation. The bigger the Inertia is, the higher the heterogeneity of pathological tissue; Entropy reflect inhomogeneity or complexity of the texture in the image, and its large value indicates a uniform texture pattern with regular changes. GLCMEnergy is the opposite, it reflects the uniformity of the gray distribution. LongRunHighGreyLevelEmphasis and LongRunLowGreyLevelEmphasis is the RLM features, which describe the roughness and smoothness of the image8,12,17. In this study, the Volume, Entropy, Inertia and LongRunHighGreyLevelEmphasis in high-risk GIST were greater than low-risk GIST, which indicated that the more heterogeneous in enhanced CT imaging, the greater the possibility of high-risk. The Correlation, GLCMEnergy in high-risk GIST were less than low-risk GIST, which indicated that the more uniform the pixel value and the more uniform the gray distribution. Among all selected parameters in this study, the numbers of gray level co-occurrence matrix and the run length matrix were the largest, which indicates that the texture distribution and spatial heterogeneity inside the tumors are closely related to tumor differentiation.
Limitations
This study has several limitations. First, in this study, ROI was selected only from the solid portion of the tumor instead of from the calcified, hemorrhagically necrotic portion inside the tumor, thereby ignoring the significance of these special components in distinguishing tumors. Second, other important clinical indicators of GIST, such as the Ki67 expression, were not studied. Finally, the practicability of the prediction model warrants further verification by the big data and multi-institutional validation to be collected from prospective studies.
Conclusions
The CT-enhanced radiomics model proposed in this paper demonstrated a good predicative power with significant potential value for the evaluation of the GIST risk status.
References
Neppala, P. et al. Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors. Cancer Metastasis Rev. 38(3), 525–535 (2019).
Li, J. & Shen, L. The current status of and prospects in research regarding gastrointestinal stromal tumors in China. Cancer 126(Suppl 9), 2048–2053 (2020).
Zhang, H. & Liu, Q. Prognostic indicators for gastrointestinal stromal tumors: a review. Transl. Oncol. 13(10), 100812 (2020).
Joensuu, H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum. Pathol. 39(10), 1411–1419 (2008).
Peng, F. & Liu, Y. Gastrointestinal stromal tumors of the small intestine: progress in diagnosis and treatment research. Cancer Manag. Res. 12, 3877–3889 (2020).
Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278(2), 563–577 (2016).
Paul, A. Y. et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31(3), 1116–1128 (2006).
Nishino, M. Radiomics to predict invasiveness of part-solid adenocarcinoma of the lung. Radiology 297, 202273 (2020).
Hoye, J., Solomon, J. B., Sauer, T. J. & Samei E. Quantification of minimum detectable difference in radiomics features across lesions and CT imaging conditions. Acad Radiol. https://doi.org/10.1016/j.acra.2020.07.029 (2021)
Park, H. J., Park, B. & Lee, S. S. Radiomics and deep learning: hepatic applications. Korean J Radiol. 21(4), 387–401 (2020).
Chu, H. et al. Value of MRI radiomics based on enhanced T1WI images in prediction of meningiomas grade. Acad. Radiol. 28, 687–693 (2020).
Park, J. E., Kickingereder, P. & Kim, H. S. Radiomics and deep learning from research to clinical workflow: neuro-oncologic imaging. Korean J Radiol. 21(10), 1126–1137 (2020).
Florou, V., Trent, J. C. & Wilky, B. A. Precision medicine in gastrointestinal stromal tumors. Discov. Med. 28(155), 267–276 (2019).
Chen, T. et al. The roles of CT and EUS in the preoperative evaluation of gastric gastrointestinal stromal tumors larger than 2 cm. Eur. Radiol. 29(5), 2481–2489 (2019).
Liu, M., Liu, L. & Jin, E. Gastric sub-epithelial tumors: identification of gastrointestinal stromal tumors using CT with a practical scoring method. Gastric Cancer 22(4), 769–777 (2019).
Mühlberg, A. et al. The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer. Eur. Radiol. 31, 834–846 (2020).
Yin, Y. Q., Liu, C. J., Zhang, B., Wen, Y. & Yin, Y. Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors. Sci. Rep. 9(1), 7257 (2019).
Wang, C. et al. Building CT radiomics-based models for preoperatively predicting malignant potential and mitotic count of gastrointestinal stromal tumors. Transl. Oncol. 12(9), 1229–1236 (2019).
Ren, C., Wang, S. & Zhang, S. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors. Cancer Imaging 20(1), 5 (2020).
Wang, C., Li, H. & Jiaerken, Y. Building CT radiomics-based models for preoperatively predicting malignant potential and mitotic count of gastrointestinal stromal tumors. Transl. Oncol. 12(9), 1229–1236 (2019).
Acknowledgements
The authors gratefully thank all the participants and staff of our team. This study was funded by Health Commission of Zhejiang Province (No. 2020KY303), the Funding of Jiangxi Province Department of Science and Technology (NO.20202BABL206112), and supported by the Funding of Guizhou Province Department of Science and Technology (NO.Qiankehe Support [2020]4Y193).
Funding
This study was funded by Health Commission of Zhejiang Province (No. 2020KY303).
Author information
Authors and Affiliations
Contributions
H.C., P.P., J.H., D.Z., M.Z., Y.Q. and X.L. wrote the main manuscript text and P.L., B.F., R.X. prepared figures and tables. All authors reviewed the manuscript. Each author has made an important scientific contribution to the study and is thoroughly familiar with the primary data. All authors listed have read the complete manuscript and have approved submission of the paper. The manuscript is truthful original work without fabrication, fraud or plagiarism. All authors declare that there is no conflict interest.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chu, H., Pang, P., He, J. et al. Value of radiomics model based on enhanced computed tomography in risk grade prediction of gastrointestinal stromal tumors. Sci Rep 11, 12009 (2021). https://doi.org/10.1038/s41598-021-91508-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-91508-5
- Springer Nature Limited
This article is cited by
-
Predicting the risk stratification of gastrointestinal stromal tumors using machine learning-based ultrasound radiomics
Journal of Medical Ultrasonics (2024)
-
Prediction of high Ki-67 proliferation index of gastrointestinal stromal tumors based on CT at non-contrast-enhanced and different contrast-enhanced phases
European Radiology (2023)
-
Radiomics in gastrointestinal stromal tumours: an up-to-date review
Japanese Journal of Radiology (2023)
-
A radiomics-clinical combined nomogram-based on non-enhanced CT for discriminating the risk stratification in GISTs
Journal of Cancer Research and Clinical Oncology (2023)
-
Risk stratification for 1- to 2-cm gastric gastrointestinal stromal tumors: visual assessment of CT and EUS high-risk features versus CT radiomics analysis
European Radiology (2022)